peritoneal cancer
Showing 1 - 25 of 116
The PIPAC PET Pilot Study, OPC-7
Not yet recruiting
- Peritoneal Cancer
- +3 more
- scan
- (no location specified)
Nov 17, 2023
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)
Recruiting
- Epithelial Ovarian Cancer
- +2 more
-
Odense, Denmark
- +3 more
Oct 16, 2023
Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)
Not yet recruiting
- Ovarian Cancer
- +5 more
- MIRRORS Protocol
- Standard Open Cytoreductive Surgery
- (no location specified)
Jul 17, 2023
Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)
Recruiting
- Cervical Cancer
- +4 more
- Patient registry
-
Seoul, Korea, Republic ofDepartment of Obstetrics and Gynecology, University of Ulsan Col
Jun 12, 2023
Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)
Not yet recruiting
- Ovary Cancer
- +2 more
- Mirvetuximab Soravtansine
- Olaparib
-
Aurora, ColoradoUniversity of Colorado Hospital
May 30, 2023
Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)
Not yet recruiting
- Primary Ovarian Cancer
- +2 more
- Huaier granule
- (no location specified)
Mar 29, 2023
Post Splenectomy Infections After Surgery for Peritoneal
Recruiting
- Post-Splenectomy Infection
- Peritoneal Cancer
- Questionnaire, interview or observation study
-
Basingstoke, Hampshire, United KingdomThe Peritoneal Malignancy Institute, Hampshire Hospitals NHS Fou
Jan 30, 2023
Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)
Not yet recruiting
- Cancer
- +4 more
- FT538
- Enoblituzumab
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Jan 24, 2023
Effectiveness in Ovarian Cancer
Completed
- Ovarian Cancer
- +5 more
- Baseline Biopsy
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)
Completed
- Epithelial Ovarian Cancer
- +2 more
- Mirvetuximab Soravtansine
-
Phoenix, Arizona
- +88 more
Jan 19, 2023
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)
Recruiting
- Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine plus Bevacizumab
- Bevacizumab
-
New Orleans, Louisiana
- +3 more
Dec 16, 2022
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in France
Completed
- Epithelial Ovarian Cancer
- +2 more
-
Agen, France
- +136 more
Dec 12, 2022
Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemo, Peritoneal Cancer Trial in Seoul (Arm I (QL block and multimodal
Recruiting
- Cytoreductive Surgery
- +2 more
- Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)
-
Seoul, Korea, Republic ofGangnam Severance Hospital
Dec 2, 2022
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- Mirvetuximab Soravtansine
-
Bengbu, Anhui, China
- +27 more
Nov 14, 2022
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine, Paclitaxel,
Active, not recruiting
- Epithelial Ovarian Cancer
- +2 more
- Mirvetuximab Soravtansine
- +3 more
-
Birmingham, Alabama
- +207 more
Oct 28, 2022
Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer Trial in Augusta (genetic testing, Survey Administration)
Not yet recruiting
- Ovarian Cancer
- +2 more
- genetic testing
- Survey Administration
-
Augusta, GeorgiaGeorgia Cancer Center at Augusta University
Oct 27, 2022
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Tampa (Aspirin 325mg, Placebo)
Suspended
- Ovarian Cancer
- +2 more
- Aspirin 325mg
- Placebo
-
Tampa, FloridaMoffitt Cancer Center
Oct 12, 2022
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Houston (Telephone Counseling, Usual Care)
Active, not recruiting
- Ovarian Cancer
- +2 more
- Telephone Counseling
- Usual Care
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, Recurrent Epithelial Ovarian Cancer Trial in Durham, Oklahoma
Recruiting
- Recurrent Ovarian Cancer
- +6 more
- Oregovomab
- Niraparib
-
Durham, North Carolina
- +2 more
Jul 26, 2022
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)
Recruiting
- Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine
-
Anchorage, Alaska
- +55 more
Jul 25, 2022
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Microdevice)
Recruiting
- Ovarian Cancer
- +6 more
- Microdevice
-
Boston, Massachusetts
- +1 more
Jul 12, 2022
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (tisotumab vedotin)
Completed
- Ovarian Cancer
- +2 more
- tisotumab vedotin
-
San Jose, California
- +36 more
Jul 8, 2022